Vepafestinib
Vepafestinib is a small molecule inhibitor targeting the RET kinase, exhibiting promising antineoplastic properties. It is utilized in oncology research to study RET-driven cancers, with applications in both in vitro biochemical assays and in vivo tumor model studies.
Product Specifications
CAS Number
2129515-96-2
Product Name Alternative
CRET, Vepafestinib, RET
Field of Research
Cell Biology, Signal Transduction
Purity
98.54% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.11 mM) ; DMSO:45 mg/mL (94.83 mM)
Smiles
COCc1ccc (NC (=O) c2c (C#CCN3CCOCC3) n (c3ncnc (N) c23) C2 (C) CC2) cc1
Molecular Formula
C26H30N6O3
Molecular Weight
474.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
125723-APC 100 µL
DDX11 (Probable ATP-dependent RNA Helicase DDX11, CHL1-related Protein 1, hCHLR1, DEAD/H Box Protein 11, Keratinocyte Growth Factor-regulated Gene 2 Protein, KRG-2, CHL1, CHLR1, KRG2) (APC)
Sign In for Pricing
View Details MBS2578009-01 24 Tests (Limit 1)
Human PD-1 (Programmed Cell Death Protein 1) ELISA Kit
Sign In for Pricing
View Details MBS2578009-02 48 Tests
Human PD-1 (Programmed Cell Death Protein 1) ELISA Kit
Sign In for Pricing
View Details MBS2578009-03 96 Tests
Human PD-1 (Programmed Cell Death Protein 1) ELISA Kit
Sign In for Pricing
View Details MBS2578009-04 5x 96 Tests
Human PD-1 (Programmed Cell Death Protein 1) ELISA Kit
Sign In for Pricing
View Details MBS2578009-05 10x 96 Tests
Human PD-1 (Programmed Cell Death Protein 1) ELISA Kit
Sign In for Pricing
View Details